Home » Archive by Category "News"

Congratulations to the 2018 Innovative Excellence Award Winners!

  Congratulations to this year’s recipients of the Innovative Excellence Award: Joel Bedford, Andrew Ray and Susan Bailey, co-founders of KromaTid, a CSU startup company that provides products and services for mutation detection and disease diagnosis. KromaTiD’s patented dGH™ chromosome

Learn More »

$35,000 Awarded at CSU Demo Day!

  Last Tuesday, April 10th, students and faculty gathered at the LSC Ballroom at CSU Demo Day, a premier event dedicated to the innovative and entrepreneurial community of CSU and Northern Colorado. Attendees gathered to hear the keynote speaker, Dr.

Learn More »
260x260

CSU Ventures sponsors Research-to-Market (R2M) Accelerator

Launchpad, a program within CSU Ventures that focuses on startup companies, has developed a customer discovery program called the Research to Market (R2M) Accelerator, that started it’s second cohort in January and finishes up in late February. R2M allows scientific

Learn More »

CSUV’s Terry Opgenorth Transforms Canine Cancer Treatment

Terry Opgenorth of Fort Collins combined his background in the pharmaceutical industry with the task of finding a research and development project for startup incubator CSU Ventures. Opgenorth, vice president and executive director of CSU Ventures, found that though pharmaceuticals developed

Learn More »

Cetya Therapeutics Announces Advanced Industries Award

  $170,000 Colorado Grant will advance Cetya’s novel targeted HDAC inhibitor program. Cetya Therapeutics, Inc. announces the award of a $170,000 Advanced Industries grant from the State of Colorado to support the development of its proprietary receptor ligand-targeted histone deacetylase

Learn More »

CSU’s Economic Impact Runs Statewide

  Spending by the university, its students, faculty and staff account for about 20 percent of the city’s sales and use tax collections, according to a 2015 economic impact study released Tuesday by the university.This analysis proves that Colorado State University

Learn More »

KromaTiD Announces Empire Oncology Partnership

  Fort Collins, CO – KromaTiD Inc. announced today that it has entered into a strategic partnership with Empire Genomics of Buffalo, NY, to provide a single, comprehensive set of genomic products and services. Targeted at oncology researchers and testing

Learn More »

VetDC Announces New TANOVEA®-CA1 Publication

  VetDC, a Colorado State University startup company, is dedicated to bringing innovative pet cancer therapeutics to market. In addition to TANOVEA-CA1 for canine lymphoma, VetDC is developing VDC-597, a novel, dual-acting PI3K/mTOR inhibitor, for multiple veterinary cancers, such as

Learn More »

State of Innovation Speaker Series Presents Dr. Tara Nealey

Estimates are that pioneering CRISPR patents will be worth hundreds of millions of dollars for patent owners. At this event, Dr. Tara Nealey of Polsinelli Law will discuss notable patent disputes, the uncertainties in the overall CRISPR patent landscape, the positioning of the surrogate

Learn More »

CSU Ventures Increases Research Involvement at CSU

  Colorado State University generated $338.4 million in research expenditures in Fiscal Year 2017, a boost of nearly 2 percent. CSU researchers were also issued a record 66 patents in that same timeframe, an indication of the university’s strength in

Learn More »

Cetya Therapeutics Announces STTR Grant Award

  Cetya Therapeutics, Inc. announces the award of a $240,000 Phase I STTR grant over a 12-month period to support the in vitro assessment of its histone deacetylase inhibitors for upregulation of fetal hemoglobin as a potential treatment modality for

Learn More »